long chain fatty acid वाक्य

उदाहरण वाक्य

1. This deficiency falls within a class of disorders called peroxisome biogenesis disorders ( PBDs ), although it is quite different from other peroxisomal disorders and does not share classic DHCA and EHCA and to a lesser extent Very long chain fatty acid and phytanic acid.
2. This is due to the fact that the beta oxidation of long chain fatty acids with an odd number of carbons produces propionyl-CoA . Most part of this metabolite is transformed into succinyl-CoA, which is the precursor of the tricarboxylic acid cycle.
3. LA is the most abundant fatty acid in the skin epidermis, being present mainly esterified to the omega-hydroxyl residue of amide-linked omega-hydroxylated very long chain fatty acids ( VLCFAs ) in a unique class of ceramides termed esterified omega-hydroxyacyl-sphingosine ( EOS ).
4. Oxidative rancidity occurs when long chain fatty acids ( like those found in soybean oil ) become oxidized due to certain conditions such as light, heat, oxygen, heavy metals, etc . It involves three steps, initiation, propagation and termination, and it results in the formation of off-flavors, off-aromas, and compounds potentially hazardous to human health.
5. Each type of leukodystrophy has a unique pathophysiology, but all five of these in some way affect a subset of glial cells, therefore disrupting myelin production and maintenance, and usually involve a mutation involving genes that code for enzymes necessary for the catabolism of very long chain fatty acids ( VLCFAs ) that are toxic to the myelin-producing cells of the central nervous system.
6. CYP2U1 hydroxylates arachidonic acid, docosahexaenoic acid ( DHA ), and other long chain fatty acids at their terminal ( i . e ., ? ) carbon to from 20-hydroxy-arachidonic acid ( i . e . 20-Hydroxyeicosatetraenoic acid or 20-HETE ), 22-hydroxy-docosahexaneoic acid, and other ?-hydroxy long chain fatty acids, respectively, plus lesser amounts of these fatty acids ?-1 hydroxy metabolites, i . e . 19-HETE, 21-hydroxy-docosahexaenoic acid, and other ?-1 hydroxy long chain fatty acids, respectively.
7. CYP2U1 hydroxylates arachidonic acid, docosahexaenoic acid ( DHA ), and other long chain fatty acids at their terminal ( i . e ., ? ) carbon to from 20-hydroxy-arachidonic acid ( i . e . 20-Hydroxyeicosatetraenoic acid or 20-HETE ), 22-hydroxy-docosahexaneoic acid, and other ?-hydroxy long chain fatty acids, respectively, plus lesser amounts of these fatty acids ?-1 hydroxy metabolites, i . e . 19-HETE, 21-hydroxy-docosahexaenoic acid, and other ?-1 hydroxy long chain fatty acids, respectively.
8. CYP2U1 hydroxylates arachidonic acid, docosahexaenoic acid ( DHA ), and other long chain fatty acids at their terminal ( i . e ., ? ) carbon to from 20-hydroxy-arachidonic acid ( i . e . 20-Hydroxyeicosatetraenoic acid or 20-HETE ), 22-hydroxy-docosahexaneoic acid, and other ?-hydroxy long chain fatty acids, respectively, plus lesser amounts of these fatty acids ?-1 hydroxy metabolites, i . e . 19-HETE, 21-hydroxy-docosahexaenoic acid, and other ?-1 hydroxy long chain fatty acids, respectively.
9. Within the active site the negatively charged oxygen on the fatty acid attacks the alpha phosphate on ATP, forming an ATP-long chain fatty acid intermediate . ( Step 1, Figure 3 ) In the second step, Pyrophosphate ( PPi ) leaves, resulting in an AMP-long chain fatty acid molecule within the enzyme s active site . ( Step 2, Figure 3 ) Coenzyme A now enters the enzyme and another intermediate is formed which consists of AMP-long chain fatty acid-Coenzyme A . ( Step 3, Figure 3 ) At the end of this mechanism two products are released, AMP and acyl coa synthetase . ( Step 4, Figure 3)
10. Within the active site the negatively charged oxygen on the fatty acid attacks the alpha phosphate on ATP, forming an ATP-long chain fatty acid intermediate . ( Step 1, Figure 3 ) In the second step, Pyrophosphate ( PPi ) leaves, resulting in an AMP-long chain fatty acid molecule within the enzyme s active site . ( Step 2, Figure 3 ) Coenzyme A now enters the enzyme and another intermediate is formed which consists of AMP-long chain fatty acid-Coenzyme A . ( Step 3, Figure 3 ) At the end of this mechanism two products are released, AMP and acyl coa synthetase . ( Step 4, Figure 3)